These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 8036745

  • 1. Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy.
    Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.
    Trans Assoc Am Physicians; 1993; 106():54-61. PubMed ID: 8036745
    [No Abstract] [Full Text] [Related]

  • 2. Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis.
    Cohen-Sacks H, Najajreh Y, Tchaikovski V, Gao G, Elazer V, Dahan R, Gati I, Kanaan M, Waltenberger J, Golomb G.
    Gene Ther; 2002 Dec; 9(23):1607-16. PubMed ID: 12424613
    [Abstract] [Full Text] [Related]

  • 3. [Gene therapy for cardiovascular disease].
    Morishita R, Ogihara T, Keneda Y.
    Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2739-45. PubMed ID: 8584730
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
    Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI.
    J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
    [Abstract] [Full Text] [Related]

  • 5. Adenovirus-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle proliferation and induces apoptosis.
    Perlman H, Luo Z, Krasinski K, Le Roux A, Mahfoudi A, Smith RC, Branellec D, Walsh K.
    Gene Ther; 1999 May; 6(5):758-63. PubMed ID: 10505098
    [Abstract] [Full Text] [Related]

  • 6. Prevention of restenosis by gene therapy.
    Kaneda Y, Morishita R, Dzau VJ.
    Ann N Y Acad Sci; 1997 Apr 15; 811():299-308; discussion 308-10. PubMed ID: 9186606
    [Abstract] [Full Text] [Related]

  • 7. Perspectives on antisense therapy for the prevention of restenosis.
    Kipshidze N, Moses J, Shankar LR, Leon M.
    Curr Opin Mol Ther; 2001 Jun 15; 3(3):265-77. PubMed ID: 11497351
    [Abstract] [Full Text] [Related]

  • 8. Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.
    Ahn JD, Morishita R, Kaneda Y, Kim HS, Chang YC, Lee KU, Park JY, Lee HW, Kim YH, Lee IK.
    Gene Ther; 2002 Dec 15; 9(24):1682-92. PubMed ID: 12457282
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Development of in vivo gene transfer methods towards future gene therapy].
    Kaneda Y, Morishita R.
    Rinsho Byori; 1997 Feb 15; 45(2):99-105. PubMed ID: 9121006
    [Abstract] [Full Text] [Related]

  • 12. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
    Preisack MB, Karsch KR.
    Eur Heart J; 1993 Nov 15; 14 Suppl I():187-92. PubMed ID: 8293774
    [Abstract] [Full Text] [Related]

  • 13. [Inhibitory effects of antisense oligonucleotides delivered locally via hydrogel catheter on myointimal hyperplasia of rat carotid artery after nitrogen drying].
    Xi Y, Wang L, Zhu G.
    Zhonghua Yi Xue Za Zhi; 1996 Feb 15; 76(2):109-11. PubMed ID: 8758441
    [Abstract] [Full Text] [Related]

  • 14. Temporal expression of c-fos mRNA following balloon injury in the rat common carotid artery.
    Mills CJ, Northrup JL, Hullinger TG, Simmons CA, Shebuski RJ, Jones DA.
    Cardiovasc Res; 1996 Nov 15; 32(5):954-61. PubMed ID: 8944827
    [Abstract] [Full Text] [Related]

  • 15. Growth-arrest homeobox gene Gax: a molecular strategy to prevent arterial restenosis.
    Maillard L, Walsh K.
    Schweiz Med Wochenschr; 1996 Oct 12; 126(41):1721-6. PubMed ID: 8893412
    [Abstract] [Full Text] [Related]

  • 16. In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.
    Lamfers ML, Lardenoye JH, de Vries MR, Aalders MC, Engelse MA, Grimbergen JM, van Hinsbergh VW, Quax PH.
    Gene Ther; 2001 Apr 12; 8(7):534-41. PubMed ID: 11319620
    [Abstract] [Full Text] [Related]

  • 17. Processing of chimeric antisense oligonucleotides by human vascular smooth muscle cells and human atherosclerotic plaque. Implications for antisense therapy of restenosis after angioplasty.
    Pickering JG, Isner JM, Ford CM, Weir L, Lazarovits A, Rocnik EF, Chow LH.
    Circulation; 1996 Feb 15; 93(4):772-80. PubMed ID: 8641007
    [Abstract] [Full Text] [Related]

  • 18. Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders.
    von der Leyen HE, Mann MJ, Dzau VJ.
    Semin Interv Cardiol; 1996 Sep 15; 1(3):209-14. PubMed ID: 9552513
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic strategies in the control of restenosis after angioplasty.
    McEwan JR.
    Exp Nephrol; 1994 Sep 15; 2(2):92. PubMed ID: 8082020
    [No Abstract] [Full Text] [Related]

  • 20. Does the effect of microRNAs in vascular neointimal formation depend on cell cycle phase?
    Silvestri P, Rigattieri S, Loschiavo P.
    Circ Res; 2008 May 09; 102(9):e101; author reply e102. PubMed ID: 18467632
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.